Picard Medical, Inc.(PMI)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $4.9M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
PMI Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Picard Medical, Inc. (PMI), a Healthcare sector company. PMI is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $4.9m in revenue. Based on the latest XBRL financial filings (Q1 2026), Picard Medical, Inc. reports quarterly revenue of $1.1M, net income of $-7.6M, free cash flow of $-3.8M. Top institutional holders of PMI by reported 13-F value include EverSource Wealth Advisors,, STATE STREET, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. PMI trades on the NYSE exchange and files with the SEC under CIK 2030617. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PMI daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Picard Medical, Inc. directly from SEC EDGAR.
Revenue
Q1 2026
$1.1M
Net Income
Q1 2026
$-7.6M
Free Cash Flow
Q1 2026
$-3.8M
AI Insight: PMI Financial Trends
Picard Medical burning cash with minimal revenue; equity swung negative by Q1 2026.
• Revenue flat at $1M across Q3 2025–Q1 2026; no growth momentum.
• Operating losses persistent: $3M–$5M per quarter; cash burn unabating.
• Equity deteriorated from $8M (Q3 2025) to $-1M (Q1 2026); balance sheet eroding.
⚠ Negative equity signals solvency stress; path to profitability or capital raise required immediately.
⚠ Operating cash flow negative each quarter; company not self-sustaining.
AI Insight: PMI Ratio Trends
Insufficient data to assess PMI's operational or financial trends; only one meaningful data point (Q4 2025 ROA of -76.1%) available.
• Q4 2025 ROA collapsed to -76.1%, indicating severe loss in that quarter.
⚠ Profitability recovery trajectory unclear; need margin and cash flow data to assess sustainability of operations.
Get alerted when PMI's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Picard Medical, Inc. including:
Top Institutional Holders of PMI
EverSource Wealth Advisors, LLC
$87.5K749 shSTATE STREET CORP
$87.1K83,751 shGEODE CAPITAL MANAGEMENT, LLC
$62.0K59,578 shAQR CAPITAL MANAGEMENT LLC
$57.5K55,262 shVANGUARD PORTFOLIO MANAGEMENT LLC
$31.4K30,208 shWealth Management Partners, LLC
$29.2K28,116 shNORTHERN TRUST CORP
$18.6K17,927 shNEW YORK STATE COMMON RETIREMENT FUND
$18.6K17,892 shCHARLES SCHWAB INVESTMENT MANAGEMENT INC
$16.8K16,130 shGround Swell Capital, LLC
$15.4K14,821 sh
| Fund | Value | Shares |
|---|---|---|
| EverSource Wealth Advisors, LLC | $87.5K | 749 |
| STATE STREET CORP | $87.1K | 83,751 |
| GEODE CAPITAL MANAGEMENT, LLC | $62.0K | 59,578 |
| AQR CAPITAL MANAGEMENT LLC | $57.5K | 55,262 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $31.4K | 30,208 |
| Wealth Management Partners, LLC | $29.2K | 28,116 |
| NORTHERN TRUST CORP | $18.6K | 17,927 |
| NEW YORK STATE COMMON RETIREMENT FUND | $18.6K | 17,892 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $16.8K | 16,130 |
| Ground Swell Capital, LLC | $15.4K | 14,821 |
More Healthcare Companies
View all Healthcare →Put PMI on your watchlist
Track score changes the day Picard Medical, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is PMI a good stock to buy?
13F Pro's AI-powered analysis of Picard Medical, Inc. (PMI) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PMI are available on the PMI stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own PMI?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PMI. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Picard Medical, Inc.'s investment landscape.